Top 10 Canadian Marijuana and Cannabis Stocks

(A Top Pick Dec 09/19, Up 30%) Still likes this long-term, but he's now focused on U.S. weed names. He prefers other names.

It's been a wild ride. The valuation across all the names are still quite high. With what we are seeing with legislation in the US, he would still tend to look at these. Stick with it.

(A Top Pick Dec 17/20, Up 132%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with APHA has progressed well. We are recommending to trail up the stop (from $8) to $19. Along with our previous recommendation to cover 50%, this would all but guarantee an minimum return on investment of 60%.

It got stuck above $30 and is now building a nice base. He likes this.

(A Top Pick Dec 15/20, Up 59.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HEXO has been progressing well. We are now recommending to trail up the stop to $7.50 (from $4.50), where we recommended covering 50% of the position previously. If triggered, this would ensure a minimum investment return exceeding 36%.

(A Top Pick Oct 04/18, Down 87%) A perfect example on staying atop your stocks. He sold around $9.88. Never fund to sell on a loss, and he did and that saved a lot of money.

He is hesitant to look into the social media companies related to the cannabis sector. He does not believe there is enough defensible on the technology side to say data gathering is a beneficial business in this space yet.

Flies under the radar, not top tier because of its size. Tremendous respect for management team. Very efficient, and that's probably why BATS invested. Will be one of the fastest growing sectors in next decade.

This company has a lot of scientific research to support the health care aspects of cannabis. They also have extensive experience in low cost farming economics as part of their partnership with Village Farms (VFF-T).

Go all in into this? Don't go all in into any cannabis stock, a sector that hasn't shown earnings yet. He has a convertible debenture of Supreme, who have executed well. But this space is now under tremendous pressure, ever since legalization.

Wouldn't buy. Firstly on principle, as they're active managers. The ETF owns the good, the bad, and the ugly. There are a lot of garbagy business models and bottom feeders out there.